Doç. Dr. Fatma Gül DEMİRKAN

1. Childhood-onset versus adult-onset Sjögren Syndrome: Clinical phenotype, disease activity, and predictors of organ damage in a national multicenter cohort

Kilic Konte E., Sahin S., Firat Sentürk E., Yekedüz Bülbül A., Arslanoglu C., Orhan Erkan M., et al.

Seminars in Arthritis and Rheumatism , cilt.80, 2026 (SCI-Expanded, Scopus)

2. Therapeutic plasma exchange in paediatric ANCA-associated vasculitis: a multicentre real-world experience

Menentoğlu B., Küçükali B., DEMİRKAN F. G., Kılbaş G., Türkmen Ş., Küçük E., et al.

Rheumatology , cilt.65, sa.9, 2026 (SCI-Expanded, Scopus)

3. Nailfold videocapillaroscopy reveals early microvascular changes in pediatric epilepsy

Perk P., ÇAKMAK F., Koç R., Dağdelen Z. Ö., Yüksel A., DEMİRKAN F. G.

Microvascular Research , cilt.166, 2026 (SCI-Expanded, Scopus)

4. Factors predicting the severity of gastrointestinal involvement in children with IgA vasculitis? A Turkish multicenter cohort study

Belder N., Acun B., Öztürk D., Kaya Yıldırım N., ÖKSEL B., Atamyıldız Uçar S., et al.

European Journal of Pediatrics , cilt.185, sa.7, 2026 (SCI-Expanded, Scopus)

5. Biological therapies in paediatric Behçet’s disease: results of an international collaborative study by the PRES Vasculitis Working Party

Akgün Ö., DEMİRKAN F. G., Koné-Paut I., Coşkuner T., Çam V., Polat M. C., et al.

Rheumatology , cilt.65, sa.3, 2026 (SCI-Expanded, Scopus)

6. Comment on: How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort: reply

Ozturk K., Aydin T., Baykal G. O., Baglan E., Kose H., Kisaoglu H., et al.

Rheumatology , cilt.65, sa.2, 2026 (SCI-Expanded, Scopus)

7. How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort

Ozturk K., Aydin T., Baykal G. O., Baglan E., Kose H., Kisaoglu H., et al.

Rheumatology , cilt.64, sa.12, ss.6278-6284, 2025 (SCI-Expanded, Scopus)

8. Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices

GEZGİN YILDIRIM D., Orulluoglu E. Y., YILDIZ Ç., AÇARI C., Dundar H. A., Akaci O., et al.

Pediatric Rheumatology , cilt.23, sa.1, 2025 (SCI-Expanded, Scopus)

9. Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study

SÖZERİ B., ŞAHİN N., AÇARI C., AVAR AYDIN P. Ö., Baba O., Bağlan E., et al.

Pediatric Rheumatology , cilt.22, sa.1, 2024 (SCI-Expanded, Scopus)

10. Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals

ŞAHİN N., Baykal G. Ö., AÇARI C., AVAR AYDIN P. Ö., Baba Ö., Bağlan E., et al.

Pediatric Rheumatology , cilt.22, sa.1, 2024 (SCI-Expanded, Scopus)

11. Do the features of juvenile psoriatic arthritis change according to age? A comprehensive evaluation of the PeRA Research Group Registry

Karadaǧ S. G., Coskuner T., DEMİRKAN F. G., SÖNMEZ H. E., Ozdel S., Çakan M., et al.

Rheumatology (United Kingdom) , cilt.63, sa.SI2, 2024 (SCI-Expanded, Scopus)

12. A clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey

Guliyeva V., DEMİRKAN F. G., Yiǧit R. E., Esen E., Baylndlr Y., TORUN R., et al.

Modern Rheumatology , cilt.34, sa.3, ss.639-645, 2024 (SCI-Expanded, Scopus)

13. PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever

Ayaz N. A., DEMİRKAN F. G., Coskuner T., Demir F., Tanatar A., Çakan M., et al.

Modern Rheumatology , cilt.34, sa.1, ss.220-225, 2024 (SCI-Expanded, Scopus)

14. Inflammatory comorbidities ın the largest pediatric Familial Mediterranean fever cohort: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG)

Ozdel S., Coşkuner T., DEMİRKAN F. G., TORUN R., Aydın E. A., Bağlan E., et al.

Clinical Rheumatology , cilt.43, sa.1, ss.407-413, 2024 (SCI-Expanded, Scopus)

15. The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study

Batu E. D., DEMİRKAN F. G., SAĞ E., Lamot L., Faleye A., Marrani E., et al.

Seminars in Arthritis and Rheumatism , cilt.63, 2023 (SCI-Expanded, Scopus)

16. Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience

Kavrul Kayaalp G., Çağlayan Ş., DEMİRKAN F. G., Guliyeva V., Otar Yener G., Öztürk K., et al.

Pediatric Rheumatology , cilt.21, sa.1, 2023 (SCI-Expanded, Scopus)

17. Not easy-peasy to diagnose: familial Mediterranean fever unaccompanied by fever

Arık S. D., Kayaalp G. K., Guliyeva V., DEMİRKAN F. G., Tanatar A., Akgün Ö., et al.

European Journal of Pediatrics , cilt.182, sa.9, ss.3983-3988, 2023 (SCI-Expanded, Scopus)

18. Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis

ÇAKMAK F., Çakan M., Demir F., SÖNMEZ H. E., Çakmak S., DEMİRKAN F. G., et al.

Rheumatology International , cilt.42, sa.7, ss.1199-1205, 2022 (SCI-Expanded, Scopus)

19. Embracing Change: An International Survey Study on the Beliefs and Attitudes of Pediatric Rheumatologists Towards Biosimilars

DEMİRKAN F. G., SÖNMEZ H. E., Lamot L., Akgün Ö., SÖZERİ B., Ayaz N. A.

BioDrugs , cilt.36, sa.3, ss.421-430, 2022 (SCI-Expanded, Scopus)

20. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study

Otar Yener G., PAÇ KISAARSLAN A., Ulu K., Atalay E., Haşlak F., Özdel S., et al.

Rheumatology International , cilt.42, sa.5, ss.879-889, 2022 (SCI-Expanded, Scopus)

21. Real-Life Data From the Largest Pediatric Familial Mediterranean Fever Cohort

Öztürk K., Coşkuner T., Baglan E., SÖNMEZ H. E., Yener G. O., ÇAKMAK F., et al.

Frontiers in Pediatrics , cilt.9, 2022 (SCI-Expanded, Scopus)

22. Approach to switching biologics in juvenile idiopathic arthritis: a real-life experience

Karadağ Ş. G., DEMİRKAN F. G., Koç R., ÇAKMAK F., SÖNMEZ H. E., Aktay Ayaz N.

Rheumatology International , cilt.42, sa.1, ss.141-147, 2022 (SCI-Expanded, Scopus)

23. Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group

DEMİRKAN F. G., Ulu K., Öztürk K., Karadağ Ş. G., Özdel S., SÖNMEZ H. E., et al.

Expert Opinion on Biological Therapy , cilt.22, sa.2, ss.197-202, 2022 (SCI-Expanded, Scopus)

24. Systemic lupus erythematosus complicated with Castleman disease: a case-based review

DEMİRKAN F. G., Doğan S., Kalyoncu Uçar A., SÖNMEZ H. E., AKTAY AYAZ N.

Rheumatology International , cilt.41, sa.2, ss.475-479, 2021 (SCI-Expanded, Scopus)

25. Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study

Ayaz N. A., Karadağ Ş. G., Koç R., DEMİRKAN F. G., ÇAKMAK F., SÖNMEZ H. E.

Rheumatology International , cilt.40, sa.7, ss.1111-1116, 2020 (SCI-Expanded, Scopus)